|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 45.66 USD | +0.22% |
|
-2.48% | -0.31% |
| 12-03 | Qiagen N.V. Presents at Evercore 8th Annual Healthcare Conference, Dec-03-2025 10:50 AM | |
| 12-02 | Qiagen N.V. Presents at Citi Annual Global Healthcare Conference 2025, Dec-02-2025 11:15 AM |
| Capitalization | 9.9B 8.5B 7.95B 7.43B 13.7B 890B 14.91B 92.18B 35.92B 422B 37.15B 36.37B 1,548B | P/E ratio 2025 * |
23.8x | P/E ratio 2026 * | 21.8x |
|---|---|---|---|---|---|
| Enterprise value | 10.23B 8.78B 8.21B 7.67B 14.16B 919B 15.4B 95.23B 37.11B 436B 38.38B 37.57B 1,599B | EV / Sales 2025 * |
4.92x | EV / Sales 2026 * | 4.6x |
| Free-Float |
97.04% | Yield 2025 * |
0.46% | Yield 2026 * | 0.41% |
More valuation ratios
* Estimated data
More news
Last Transcript: Qiagen N.V.
More recommendations
More press releases
More news
| 1 day | +0.22% | ||
| 1 week | -2.48% | ||
| Current month | -4.38% | ||
| 1 month | +5.77% | ||
| 3 months | -0.76% | ||
| 6 months | -1.21% | ||
| Current year | -0.31% |
| 1 week | 45.54 |  | 47.48 |
| 1 month | 43.59 | | 48.69 |
| Current year | 37.63 | | 51.88 |
| 1 year | 37.63 | | 51.88 |
| 3 years | 36.84 | | 54.27 |
| 5 years | 36.84 | | 62.56 |
| 10 years | 21.96 | | 62.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thierry Bernard
CEO | Chief Executive Officer | 60 | 06/10/2019 |
Roland Sackers
DFI | Director of Finance/CFO | 57 | 31/12/2003 |
Antonio Santos
COO | Chief Operating Officer | - | 31/03/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Metin Colpan
BRD | Director/Board Member | 70 | 31/12/2003 |
| Director/Board Member | 76 | 31/05/2011 | |
Ross Levine
BRD | Director/Board Member | 53 | 31/12/2015 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 3.1% | 1 M€ | 0.00% | - |
| 1.65% | 2 M€ | -.--% | - |
| 1.32% | 148 M€ | +17.35% | - |
| 1.08% | 5 M€ | 0.00% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.22% | -2.48% | -3.64% | -12.60% | 9.9B | |
| -1.86% | -3.36% | +1.45% | +14.37% | 47.04B | |
| +2.23% | -1.90% | +9.70% | +6.90% | 37.96B | |
| +1.25% | -4.49% | +72.10% | +63.80% | 35.71B | |
| -0.85% | +1.31% | +11.36% | +16.84% | 27.64B | |
| +3.06% | -2.73% | +63.99% | +172.51% | 15.8B | |
| +0.09% | +0.24% | +64.69% | +227.50% | 15.06B | |
| +2.52% | -1.02% | -13.94% | -4.57% | 14.19B | |
| -1.07% | +0.21% | +66.82% | - | 13.36B | |
| -0.29% | -3.92% | +105.51% | +109.68% | 12.74B | |
| Average | +0.80% | -1.72% | +37.80% | +66.05% | 22.94B | |
| Weighted average by Cap. | +0.55% | -1.94% | +31.88% | +51.10% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2.08B 1.78B 1.67B 1.56B 2.88B 187B 3.13B 19.34B 7.54B 88.52B 7.8B 7.63B 325B | 2.2B 1.89B 1.77B 1.65B 3.05B 198B 3.32B 20.5B 7.99B 93.8B 8.26B 8.09B 344B |
| Net income | 421M 361M 338M 316M 582M 37.83B 634M 3.92B 1.53B 17.93B 1.58B 1.55B 65.8B | 460M 395M 369M 345M 636M 41.32B 692M 4.28B 1.67B 19.58B 1.72B 1.69B 71.87B |
| Net Debt | 327M 281M 263M 245M 453M 29.4B 493M 3.05B 1.19B 13.93B 1.23B 1.2B 51.14B | 235M 202M 189M 176M 325M 21.1B 354M 2.19B 852M 10B 881M 862M 36.71B |
More financial data
* Estimated data
Employees
5,700
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/12/25 | 45.66 $ | +0.22% | 875,022 |
| 09/12/25 | 45.56 $ | -0.65% | 860,842 |
| 08/12/25 | 45.86 $ | -2.45% | 1,356,343 |
| 05/12/25 | 47.01 $ | -0.15% | 1,854,330 |
| 04/12/25 | 47.08 $ | +0.56% | 1,851,787 |
Delayed Quote Nyse, December 10, 2025 at 09:00 pm
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
45.66USD
Average target price
50.79USD
Spread / Average Target
+11.23%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- QGEN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition